These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Memantine (Ebixa) in clinical practice - results of an observational study. Calabrese P; Essner U; Forstl H Dement Geriatr Cogn Disord; 2007; 24(2):111-7. PubMed ID: 17622714 [TBL] [Abstract][Full Text] [Related]
25. Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease. Waldemar G; Hyvärinen M; Josiassen MK; Kørner A; Lehto H; Wetterberg P Int J Geriatr Psychiatry; 2008 Sep; 23(9):979-81. PubMed ID: 18229874 [No Abstract] [Full Text] [Related]
26. Review of donepezil, rivastigmine, galantamine and memantine for the treatment of dementia in Alzheimer's disease in adults with Down syndrome: implications for the intellectual disability population. Prasher VP Int J Geriatr Psychiatry; 2004 Jun; 19(6):509-15. PubMed ID: 15211527 [TBL] [Abstract][Full Text] [Related]
27. Alzheimer disease. Donepezil and nursing home placement--benefits and costs. Jelic V; Winblad B Nat Rev Neurol; 2016 Jan; 12(1):11-3. PubMed ID: 26714658 [TBL] [Abstract][Full Text] [Related]
28. Acetylcholinesterase inhibitors and memantine in bipolar disorder: A systematic review and best evidence synthesis of the efficacy and safety for multiple disease dimensions. Veronese N; Solmi M; Luchini C; Lu RB; Stubbs B; Zaninotto L; Correll CU J Affect Disord; 2016 Jun; 197():268-80. PubMed ID: 27010579 [TBL] [Abstract][Full Text] [Related]
32. [Efficacy, efficiency and evidence -- studies on donepezil]. Wallesch CW; Ebert AD Fortschr Neurol Psychiatr; 2004 Oct; 72(10):555-6. PubMed ID: 15472778 [No Abstract] [Full Text] [Related]
33. [New options for the pharmacotherapy of Alzheimer disease after the approval of memantine? Re the article from DMW 8/2005]. Wellhöfer B Dtsch Med Wochenschr; 2006 Feb; 131(6):284. PubMed ID: 16463237 [No Abstract] [Full Text] [Related]
34. New drug treatment for Alzheimer's disease. SMAC's advice on use of donepezil is contradictory. Baxter T; Black D; Prempeh H BMJ; 1998 Oct; 317(7163):946. PubMed ID: 9841011 [No Abstract] [Full Text] [Related]
35. FDA approves memantine drug for treating AD. Am J Alzheimers Dis Other Demen; 2003; 18(6):329-30. PubMed ID: 14682078 [No Abstract] [Full Text] [Related]
36. Improving functioning in patients with Alzheimer's. J Psychosoc Nurs Ment Health Serv; 1998 May; 36(5):11-2. PubMed ID: 9604834 [No Abstract] [Full Text] [Related]